CD8A and COVID-19: Our study has also investigated in transplant patients the possible influence of the reduction of T lymphocytes, NK cells and the CD4+CD8+ lymphocyte ratio, associated with COVID-19, on the greater tendency for EBV DNA reactivation in order to explore a possible influence of the altered immune system on EBV reactivation.